LIPOPROTEIN PRODUCTS OF LECITHIN - CHOLESTEROL ACYLTRANSFERASE AND CHOLESTERYL ESTER TRANSFER

被引：6
|
作者：
ROSE, HG
ELLERBE, P
机构：
来源：
BIOCHIMICA ET BIOPHYSICA ACTA | 1982年 / 712卷 / 03期
关键词：
D O I：
10.1016/0005-2760(82)90283-1
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：547 / 556
页数：10
相关论文
共 50 条
  • [21] ROLE OF ELEVATED LECITHIN - CHOLESTEROL ACYLTRANSFERASE AND CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITIES IN ABNORMAL LIPOPROTEINS FROM PROTEINURIC PATIENTS
    DULLAART, RPF
    GANSEVOORT, RT
    DIKKESCHEI, BD
    DEZEEUW, D
    DEJONG, PE
    VANTOL, A
    [J]. KIDNEY INTERNATIONAL, 1993, 44 (01) : 91 - 97
  • [22] Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin: cholesterol acyltransferase in end-stage renal disease (ESRD)
    Pahl, Madeleine V.
    Ni, Zhenmin
    Sepassi, Lili
    Moradi, Hamid
    Vaziri, Nosratola D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (08) : 2541 - 2546
  • [23] EFFECT OF ADDED LECITHIN ON THE ESTERIFICATION OF LIPOPROTEIN CHOLESTEROL BY LECITHIN-CHOLESTEROL ACYLTRANSFERASE
    WIESSNER, JH
    KUMMEROW, FA
    NISHIDA, T
    [J]. FEDERATION PROCEEDINGS, 1979, 38 (03) : 335 - 335
  • [24] IDENTIFICATION OF PHYSIOLOGICAL SUBSTRATE FOR LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) AND DEMONSTRATION OF ENDOGENOUS CHOLESTERYL ESTER TRANSFER (CETP) ACTIVITY IN PLASMA
    CHEN, CH
    [J]. ARTERIOSCLEROSIS, 1988, 8 (05): : A556 - A556
  • [25] The effect of atorvastatin therapy on hdl subfractions, lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and human paraoxonase-1
    Paragh, G. Y.
    Kassai, A.
    Sztanek, F.
    Illyes, L.
    Mirdamadi, H. Z.
    Seres, I.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 203 - 203
  • [26] LOCALIZATION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) AND CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) ACTIVITIES IN A-I-CONTAINING LIPOPROTEINS
    CHEUNG, MC
    WOLF, AC
    LUM, KD
    TOLLEFSON, JH
    ALBERS, JJ
    [J]. CIRCULATION, 1985, 72 (04) : 365 - 365
  • [27] EFFECTS OF BEZAFIBRATE THERAPY ON SUBFRACTIONS OF PLASMA LOW-DENSITY-LIPOPROTEIN AND HIGH-DENSITY-LIPOPROTEIN, AND ON ACTIVITIES OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE AND CHOLESTERYL ESTER TRANSFER PROTEIN IN PATIENTS WITH HYPERLIPOPROTEINEMIA
    HOMMA, Y
    OZAWA, H
    KOBAYASHI, T
    YAMAGUCHI, H
    SAKANE, H
    MIKAMI, Y
    MIKAMI, Y
    NAKAMURA, H
    [J]. ATHEROSCLEROSIS, 1994, 106 (02) : 191 - 201
  • [28] Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice
    Föger, B
    Chase, M
    Amar, MJ
    Vaisman, BL
    Shamburek, RD
    Paigen, B
    Furchart-Najib, J
    Paiz, JA
    Koch, CA
    Hoyt, RF
    Brewer, HB
    Santamarina-Fojo, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (52) : 36912 - 36920
  • [29] Cholesteryl ester transfer protein and lecithin: Cholesterol acyltransferase activities in Hispanic and Anglo postmenopausal women: Associations with total and regional body fat
    Greaves, KA
    Going, SB
    Fernandez, ML
    Milliken, LA
    Lohman, TG
    Bassford, T
    McNamara, DJ
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (03): : 282 - 289
  • [30] Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemia
    Napoli, C
    Leccese, M
    Palumbo, G
    de Nigris, F
    Chiariello, P
    Zuliani, P
    Somma, P
    Di Loreto, M
    De Matteis, C
    Cacciatore, F
    Abete, P
    Liguori, A
    Chiariello, M
    D'Armiento, FP
    [J]. CORONARY ARTERY DISEASE, 1998, 9 (05) : 257 - 264
12345